Wealth Enhancement Advisory Services
MED icon

Wealth Enhancement Advisory Services’s Medifast MED Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115K Buy
10,683
+385
+4% +$4.44K ﹤0.01% 3768
2026
Q1 		$107K Buy
+10,298
New +$111K ﹤0.01% 3304

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wealth Enhancement Advisory Services's MED Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Medifast (MED) stake by 3.7% in Q2 2026, buying an estimated $4.44K and bringing the position to 10,683 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #3768.

Wealth Enhancement Advisory Services first reported a position in MED in Q1 2026 and has held it in 2 quarters since. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Wealth Enhancement Advisory Services held 10,683 shares of Medifast worth $115K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 385 Medifast shares in Q2 2026, an estimated $4.44K.
  • Medifast made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3768 holding.
  • Wealth Enhancement Advisory Services first reported a position in Medifast in Q1 2026 and has held it in 2 quarters since.
  • 112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.